GS Pharma Solutions, LLC is a consulting company led by Greg Stevens and provides nonclinical toxicology consulting services for biopharmaceutical companies. We have experience with small and large molecules across multiple therapeutic areas, bringing multiple compounds through IND and registration. A large bulk of my experience is in the Oncology space with kinase inhibitors, ADCs, mAbs, epigenetics and metabolism targets.

The following are areas of expertise:

• Target and compound selection strategies including target safety reviews
• Regulatory toxicology studies required to support every stage of drug development
• Oversee studies at CROs, report review and writing regulatory documents
• Prepare briefing documents and represent clients at regulatory agencies
• Address safety issues that arise in animals or humans
• Experience with both small and large molecules, including immuno-oncology and ADCs
• Extensive experience in safety strategy for kinase drug discovery and development
• Provide nonclinical expertise for due-diligence reviews
• Expertise in developing people, project teams and scientific departments
• Provide post-merger integration strategies for life science industry